2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of thePreclinical CRO Market?
The preclinical CRO market is anticipated to witness growth driven by the rising need for preclinical trials. These trials are essentially studies of medical treatments or drugs prior to them being tested on human volunteers. They typically focus on new medical devices, prescription medications, and diagnostic tests, with the main goals being to identify a safe initial dose for human trials and assess the potential toxicity of the product. They are crucial in the process of drug development, gaining more importance with the increased focus on safety and effectiveness of new drugs. For example, in February 2024, IQVIA, a U.S. company that serves the health information technology and clinical research industries, reported an increase in clinical development productivity in 2023. The report showed the launch of 69 new active substances (NASs) worldwide in 2023, which was 6 more than the previous year, and included 24 first-in-class launches in the U.S. Hence, the growing demand for preclinical trials is contributing to the progression of the preclinical CRO market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10303&type=smp
#What Long-Term Growth Rate is Expected for thePreclinical CRO Market Between 2025 and 2034?
The market size of preclinical CRO has seen substantial growth in the past few years. The market, which was valued at $5.7 billion in 2024, is projected to escalate to $6.26 billion in 2025, delivering a compound annual growth rate (CAGR) of 9.9%. The considerable growth during the prior period has been propelled by the need for swift drug development, strategic cost control, concentration on key competencies, mandatory regulatory compliance, and the international expansion of clinical trials.
There is an anticipation for significant expansion in the preclinical CRO market in the upcoming years. It’s projected to rise to “$9.06 billion in 2029 with a compound annual growth rate (CAGR) of 9.7%. This surge in the forecast period is due to several factors including the emergence of personalized medicine, a concentrated focus on rare diseases and orphan drugs, increased reliance on outsourcing within biopharmaceuticals, a drive towards biomarker research, and a growing necessity for real-world evidence generation. Key trends expected during this forecast period are the incorporation of artificial intelligence (AI), growth within oncology research, progress in omics technologies, advancements in in vitro and in vivo models, along with an increased emphasis on collaboration for translational research.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10303
Which Upcoming Market Trends and Innovations Are Set to Influence the Preclinical CRO Market’s Path Forward?
The surge in technological innovations is an emerging trend gaining traction in the preclinical CRO market. Key players in this market are utilizing new technologies to maintain their market stance. For instance, BenchSci, an AI solutions firm for preclinical R&D situated in Canada, introduced ASCEND in February 2023. This end-to-end SaaS platform is designed for preclinical drug discovery. The method aims to expedite preclinical phase drug development pipelines by acquiring biological knowledge of disease causes. ASCEND employs BenchSci’s machine-learning technology to pull experimental information from secured internal and public external sources. The platform subsequently evaluates experimental outcomes using carefully selected ontology datasets. Hence, the software can generate a map outlining the biological processes that trigger various diseases, utilizing evidence-based data.
Who Are the Dominant Market Players Pushing the Boundaries of thePreclinical CRO Market?
Major companies operating in the preclinical CRO market include Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec Co. Ltd., Medpace Holdings Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Simavita Ltd., BioEmission Technology Solutions, Altasciences Company Inc., Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd., ICON plc, Kunming Biomed International Ltd., PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc., Syngene International Limited
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report
#thebusinessresearchcompany #marketresearch #marketintelligence
The preclinical CRO market covered in this report is segmented –
1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services
2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model
3) By Animal Model: Small Animal Model, Large Animal Model
4) By Model System: In Vivo, In Vitro
5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users
Subsegments:
1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies, Pharmacodynamics Studies, Drug Metabolism Studies
2) By Toxicology Testing: Acute Toxicity Testing, Chronic Toxicity Testing, Reproductive Toxicity Testing
3) By Compound Management: Sample Management, Inventory Management, Formulation Services
4) By Chemistry: Medicinal Chemistry, Analytical Chemistry, Synthetic Chemistry
5) By Safety Pharmacology: Cardiovascular Safety Studies, Central Nervous System Safety Studies, Respiratory Safety Studies
6) By Other Services: Regulatory Consulting, Project Management, Data Management Services
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10303&type=smp
What Regions Are Dominating the Preclinical CRO Market Growth?
North America was the largest region in the preclinical CRO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical CRO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Preclinical CRO Maret 2025, By The Business Research Company:
Biosimilar Lymphocyte Modulator Global Market Report 2024
Tumor Infiltrating Lymphocytes Global Market Report 2024
Blood Group Typing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
